I Have LINK: Article : Analysts Raising CLDX Target. Roth Capital Says Buy with $16 Target. POSTED.
US Market Buzz 3/7/13
Analysts’ call: eBay Inc (NASDAQ:EBAY), Celldex Therapeutics, Inc. (NASDAQ:CLDX)
March 7, 2013 by Karen Loftus in Technology
In other news, Leerink Swann has initiated coverage for Celldex Therapeutics, Inc.(NASDAQ:CLDX) with a rating of Outperfrom. It set a price target of $18.
Howard Liang, an analyst said that the range of Celldex Therapeutics is rare among small and mid-sized biotech enterprises, with 6 entirely owned clinical-stage biologics assets offering multiple shots on goal.
A number of other companies have also commented on Celldex recently. Oppenheimer analysts have upped their price targets on the Celldex stock to $13 and have rated it an Outperform. Roth Capital analysts have reinstated a Buy rating on the Celldex shares and presently hold a price target of $16 on the stock.
Cantor Fitzgerald analysts have also increased their price target on the biotech company’s stock to $13 and have rated it a Buy.